Transplantation

Random

Therapy for Kidney Transplant Recipients Harnesses Existing Cancer Drug

Left: This scanning electron microscope image shows SARS-CoV-2 (round magenta objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Source: NIAID-RML. Right: Dr. Gang Chen, MD, PhD, the senior author of a recent case report published in the American Journal of Transplantation that outlined the recovery of an immunosuppressed transplant recipient from COVID-19.

Immunosuppressed Transplant Recipient Recovers from COVID-19

IL-21 Positive Cells Predict Kidney Transplant Rejection Prior to Surgery

Photopheresis Found to Treat GvHD By Favorably Altering WBC Profile

News

ImmunoFrontiers LLC © 2019-2022. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

SUBSCRIBE
error: Content is protected.